{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:42:59Z","timestamp":1791855779216,"version":"4.3.4"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>The Zhejiang University (ZJU) index is an established surrogate marker for metabolic dysfunction-associated steatotic liver disease (MASLD). We aimed to investigate the association between ZJU index and hyperuricemia in patients with type 2 diabetes mellitus (T2DM).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a retrospective cross-sectional analysis of 1772 adults with T2DM at the Affiliated Hospital of Jiangsu University. The ZJU index was derived from clinical metabolic variables, and participants were classified by hyperuricemia status. Associations between the ZJU index and hyperuricemia were examined using multivariable regression, restricted cubic spline modeling, and subgroup analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Patients with hyperuricemia exhibited significantly worse metabolic profiles, including higher ZJU index levels (P&amp;lt;0.001). The ZJU index demonstrated a significant positive association with the prevalence of hyperuricemia (OR\u00a0=\u00a01.036, 95%CI: 1.017-1.056, P&amp;lt;0.001) and serum uric acid levels (\u03b2=1.187, 95%CI: 0.595-1.780, P&amp;lt;0.001), with a graded increase observed across quantiles (P for trend&amp;lt;0.001). Restricted cubic spline analysis further indicated a linear relationship. The association showed overall consistency across subgroups, while a stronger effect was evident in participants with coronary heart disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The ZJU index is associated with hyperuricemia in T2DM and may reflect interlinked hepato-metabolic pathways that drive hyperuricemia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1836849","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T04:21:15Z","timestamp":1776918075000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Association between the Zhejiang University index and hyperuricemia among adults with type 2 diabetes in China"],"prefix":"10.3389","volume":"17","author":[{"given":"Haoxiang","family":"Li","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Institute of Endocrine and Metabolic Diseases, Affiliated Hospital of Jiangsu University, Jiangsu University","place":["Zhenjiang, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Affiliated Hospital of Jiangsu University, Jiangsu University","place":["Zhenjiang, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Institute of Endocrine and Metabolic Diseases, Affiliated Hospital of Jiangsu University, Jiangsu University","place":["Zhenjiang, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Institute of Endocrine and Metabolic Diseases, Affiliated Hospital of Jiangsu University, Jiangsu University","place":["Zhenjiang, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Institute of Endocrine and Metabolic Diseases, Affiliated Hospital of Jiangsu University, Jiangsu University","place":["Zhenjiang, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Institute of Endocrine and Metabolic Diseases, Affiliated Hospital of Jiangsu University, Jiangsu University","place":["Zhenjiang, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoyue","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Institute of Endocrine and Metabolic Diseases, Affiliated Hospital of Jiangsu University, Jiangsu University","place":["Zhenjiang, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-0441-1","article-title":"Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors","volume":"16","author":"Dehlin","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22179221","article-title":"Molecular biological and clinical understanding of the pathophysiology and treatments of hyperuricemia and its association with metabolic syndrome, cardiovascular diseases and chronic kidney disease","volume":"22","author":"Yanai","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-024-01295-3","article-title":"Hyperuricemia: an intriguing connection to metabolic syndrome, diabetes, kidney disease, and hypertension","volume":"26","author":"Vareldzis","year":"2024","journal-title":"Curr Hypertens Rep"},{"key":"B4","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41392-024-01916-y","article-title":"Hyperuricemia and its related diseases: mechanisms and advances in therapy","volume":"9","author":"Du","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2020.07.006","article-title":"Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease","author":"Borghi","year":"2020","journal-title":"Eur J Intern Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2024.108929","article-title":"Uric acid in diabetic microvascular complications: mechanisms and therapy","volume":"39","author":"Li","year":"2025","journal-title":"J Diabetes Complications"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/medicina61112042","article-title":"Integrating renal and metabolic parameters into a derived risk score for hyperuricemia in uncontrolled type 2 diabetes: a retrospective cross-sectional study in Northwest Romania","volume":"61","author":"Paduraru","year":"2025","journal-title":"Med (Kaunas)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1186\/s12944-025-02760-x","article-title":"Associations of the Zhejiang University (ZJU) index with cardiovascular diseases and mortality among US adults: a national cohort study","volume":"24","author":"Mo","year":"2025","journal-title":"Lipids Health Dis"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v16.i12.115435","article-title":"From fatty liver indices to the Zhejiang University index: re-shaping risk stratification of metabolic liver disease in diabetes","volume":"16","author":"Gouda","year":"2025","journal-title":"World J Diabetes"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v16.i12.114565","article-title":"Zhejiang University index predicts metabolic dysfunction-associated steatotic liver disease in type 2 diabetes mellitus patients","volume":"16","author":"Zhang","year":"2025","journal-title":"World J Diabetes"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2025.120747","article-title":"Association between the ZJU index and depression in US adults: a cross-sectional NHANES analysis","volume":"395","author":"Cheng","year":"2026","journal-title":"J Affect Disord"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmedr.2025.103225","article-title":"Association between a diabetes-predictive index and diabetes-related kidney disease in U.S. adults: a cross-sectional study","volume":"58","author":"Wu","year":"2025","journal-title":"Prev Med Rep"},{"key":"B13","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1186\/s12944-024-02373-w","article-title":"The ZJU index is associated with the risk of sarcopenia in American adults aged 20-59: a cross-sectional study","volume":"23","author":"Hao","year":"2024","journal-title":"Lipids Health Dis"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1570771","article-title":"ZJU index as a predictive biomarker of gestational diabetes mellitus: a prospective cohort analysis","volume":"12","author":"Xu","year":"2025","journal-title":"Front Nutr"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2025.1608648","article-title":"Nonlinear association of a composite metabolic index (ZJU index) with hypertension: a cross-sectional study of NHANES 2003-2018","volume":"12","author":"Gong","year":"2025","journal-title":"Front Cardiovasc Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1186\/s12889-024-20457-1","article-title":"Association between body mass index and serum uric acid: mediation analysis involving liver enzymes indicators","volume":"24","author":"Deng","year":"2024","journal-title":"BMC Public Health"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1133515","article-title":"Fatty liver mediates the association of hyperuricemia with prediabetes and diabetes: a weighting-based mediation analysis","volume":"14","author":"Basnet","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2026.1764219","article-title":"Association between different metabolic obesity phenotypes and hyperuricemia: the modifying role of liver enzymes","volume":"14","author":"Guo","year":"2026","journal-title":"Front Public Health"},{"key":"B19","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1001\/jamainternmed.2022.6817","article-title":"Prevalence of chronic kidney disease in China: results from the sixth China chronic disease and risk factor surveillance","volume":"183","author":"Wang","year":"2023","journal-title":"JAMA Intern Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/srep16494","article-title":"ZJU index: a novel model for predicting nonalcoholic fatty liver disease in a Chinese population","volume":"5","author":"Wang","year":"2015","journal-title":"Sci Rep"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1340644","article-title":"Association between the ZJU index and risk of new-onset non-alcoholic fatty liver disease in non-obese participants: a Chinese longitudinal prospective cohort study","volume":"15","author":"Zheng","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1136\/jim-2020-001608","article-title":"Renal lipid accumulation, oxidative stress and uric acid handling in a rodent model of obesity and metabolic syndrome","author":"Rosenthal","year":"2020","journal-title":"J Investig Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1186\/s12967-020-02590-8","article-title":"Association of hypertension and hypertriglyceridemia on incident hyperuricemia: an 8-year prospective cohort study","volume":"18","author":"Zhang","year":"2020","journal-title":"J Transl Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/art.41779","article-title":"Assessing the causal relationships between insulin resistance and hyperuricemia and gout using bidirectional Mendelian randomization","volume":"73","author":"McCormick","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1637543","article-title":"Association between the triglyceride-glucose index and hyperuricemia: potential role of obesity in patients with type 2 diabetes mellitus","volume":"16","author":"Tang","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1666563","article-title":"Association between the triglyceride-glucose index and hyperuricemia in patients with type 2 diabetes mellitus","volume":"16","author":"Sun","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2017.10.009","article-title":"Higher triglyceride level predicts hyperuricemia: a prospective study of 6-year follow-up","volume":"12","author":"Zhang","year":"2018","journal-title":"J Clin Lipidol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1645766","article-title":"Triglycerides as a mediator in the hyperuricemia-diabetes link: insights from a hypertensive Chinese population","volume":"16","author":"Lu","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1457598","article-title":"Elevated ALT\/AST ratio as a marker for NAFLD risk and severity: insights from a cross-sectional analysis in the United States","volume":"15","author":"Xuan","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.dmpk.2020.06.006","article-title":"Mathematical modeling analysis of hepatic uric acid disposition using human sandwich-cultured hepatocytes","volume":"35","author":"Wada","year":"2020","journal-title":"Drug Metab Pharmacokinet"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2026.1720601","article-title":"Uric acid and hyperuricemia in relation to non-alcoholic fatty liver disease among individuals with type 2 diabetes: insights from a cross-sectional analysis","volume":"17","author":"Li","year":"2026","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B32","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/s12876-025-03917-9","article-title":"Gender difference in the association between serum uric acid and metabolic dysfunction-associated steatotic liver disease in patients with newly diagnosed type 2 diabetes","volume":"25","author":"Cui","year":"2025","journal-title":"BMC Gastroenterol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2026.2644681","article-title":"Gut microbiota metabolic reprogramming drives the development of metabolic diseases in the host","volume":"18","author":"Wang","year":"2026","journal-title":"Gut Microbes"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14829","article-title":"Interconnection between cardiovascular, renal and metabolic disorders: a narrative review with a focus on Japan","volume":"24","author":"Kadowaki","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2025.1661563","article-title":"Pathophysiology and emerging biomarkers of cardiovascular-renal-hepato-metabolic syndrome","volume":"12","author":"Nzobokela","year":"2025","journal-title":"Front Cardiovasc Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202300393R","article-title":"Hyperuricemia: a key contributor to endothelial dysfunction in cardiovascular diseases","volume":"37","author":"Wei","year":"2023","journal-title":"FASEB J"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23063188","article-title":"Uric acid and oxidative stress-relationship with cardiovascular, metabolic, and renal impairment","volume":"23","author":"Gherghina","year":"2022","journal-title":"Int J Mol Sci"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1836849\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T04:21:16Z","timestamp":1776918076000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1836849\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,23]]},"references-count":37,"alternative-id":["10.3389\/fendo.2026.1836849"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1836849","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,23]]},"article-number":"1836849"}}